Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene
- 276 Downloads
Familial hypercholesterolemia (FH), an autosomal dominant inherited disorder resulting in increased levels of circulating plasma low-density lipoprotein (LDL), tendon xanthomas and premature coronary artery disease (CAD), is caused by defects in the LDL receptor gene (LDLR). Three widespread LDLR alterations not causing FH (c.1061-8T>C, c.2177C>T and c.829G>A) and one mutation (c.12G>A) with narrow geographical distribution and thought to cause disease were investigated. In an attempt to improve knowledge on their origin, spread and possible selective effects, estimations of the ages of these variants (t generations) and haplotype analysis were performed by genotyping 86 healthy individuals and 98 FH patients in Spain for five LDLR SNPs: c.81T>C, c.1413G>A, c.1725C>T, c.1959T>C, and c.2232G>A; most patients carried two of these LDLR variants simultaneously. It was found that both the c.1061-8T>C (t = 54) and c.2177C>T alterations (t = 62) arose at about the same time (54 and 62 generations ago, respectively) in the CGCTG haplotype, while the c.12G>A mutation (t = 70) appeared in a CGCCG haplotype carrying an earlier c.829G>A alteration (t = 83). The estimated ages of selectively neutral alterations could explain their distribution by migrations. The origin of the c.12G>A mutation could be in the Iberian Peninsula; despite its estimated age, a low selective pressure could explain its conservation in Spain from where it could have spread to China and Mexico, since the sixteenth century through the Spanish/Portuguese colonial expeditions.
KeywordsAge of mutations inference Familial hypercholesterolemia Linkage disequilibrium Populations history Tag SNPs
The authors thank Dr. D. Savva (University of Reading, UK) for his help with the English manuscript. This study was funded by Grants from the Spanish Ministry of Health FIS PI06/0365 and RTIC C06/01(RECAVA: Cooperative Cardiovascular Disease Research Network). The authors also thank CIBERER (Biomedical Network Research Centre on Rare Diseases).Ethical standards: The authors declare that the experiments carried out in this study comply with the current Spanish laws.
Conflict of interest statement
The authors declare that they have no conflict of interest.
- Alharbi KK, Aldahmesh MA, Spanakis E, Haddad L, Whittall RA, Chen XH, Rassoulian H, Smith MJ, Sillibourne J, Ball NJ, Graham NJ, Briggs PJ, Simpson IA, Phillips DI, Lawlor DA, Ye S, Humphries SE, Cooper C, Smith GD, Ebrahim S, Eccles DM, Day IN (2005) Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Res 15:967–977CrossRefPubMedGoogle Scholar
- Castillo S, Reyes G, Tejedor D, Mozas P, Suarez Y, Lasuncion MA, Cenarro A, Civeira F, Alonso R, Mata P, Pocovi M, Spanish Group of FH (2002) A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease. Hum Mutat 20:477CrossRefPubMedGoogle Scholar
- Cebrián JA (2002) La aventura de los Godos. Circulo de Lectores, Barcelona, p 204Google Scholar
- Cenarro A, Jensen HK, Casao E, Civeira F, González Bonillo J, Rodríguez Rey JC, Gregersen N, Pocoví M (1998) Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online. Hum Mutat 11:413CrossRefPubMedGoogle Scholar
- Chaves FJ, Real JT, Garcia-Garcia AB, Civera M, Armengol ME, Ascaso JF, Carmena R (2001) Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL and high-density lipoprotein cholesterol. J Clin Endocrinol Metab 86:4926–4932CrossRefPubMedGoogle Scholar
- Durst R, Colombo R, Shpitzen S, Avi LB, Friedlander Y, Wexler R, Raal FJ, Marais DA, Defesche JC, Mandelshtam MY, Kotze MJ, Leitersdorf E, Meiner V (2001) Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet 68:1172–1188CrossRefPubMedGoogle Scholar
- Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 2863–2913Google Scholar
- Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Giménez J, Reis A, Varon-Mateeva R, Macek M Jr, Kalaydjieva L, Angelicheva D, Dancheva R, Romeo G, Russo MP, Garnerone S, Restagno G, Ferrari M, Magnani C, Claustres M, Desgeorges M, Schwartz M, Schwartz M, Dallapiccola B, Novelli G, Ferec C, de Arce M, Nemetti M, Kere J, Anvret M, Dhal N, Kadeshi L (1994) The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet 7:169–175CrossRefPubMedGoogle Scholar
- Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR, Soutar AK (1998) Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same of similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol 18:309–315PubMedGoogle Scholar
- Rannala B, Reeve JP (2003) Joint Bayesian estimation of mutation location and age using linkage disequilibrium. Pacific Symposium on Biocomputing, Lihue, Hawaii, USA, 8:526–534, 3–7 January 2003. http://helix-web.stanford.edu/psb03/#humvar (accessed 17 February 2010)
- Robles-Osorio L, Huerta-Zepeda A, Ordóñez ML, Canizales-Quinteros S, Díaz-Villaseñor A, Gutiérrez-Aguilar R, Riba L, Huertas-Vázquez A, Rodríguez-Torres M, Gómez-Díaz RA, Salinas S, Ongay-Larios L, Codiz-Huerta G, Mora-Cabrera M, Mehta R, Gómez Pérez FJ, Rull JA, Rabès JP, Tusié-Luna MT, Durán-Vargas S, Aguilar-Salinas CA (2006) Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch Med Res 37:102–108CrossRefPubMedGoogle Scholar
- Sanchez-Cerezo S (ed) (1995) Atlas histórico universal. El Pais-Aguilar, Madrid, pp 44–45, 91, 95, 103, 113 and 139Google Scholar
- Tejedor D, Castillo S, Mozas P, Jiménez E, López M, Tejedor MT, Artieda M, Alonso R, Mata P, Simón L, Martínez A, Pocoví M, on behalf of the Spanish FH group (2005) Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51:1137–1144CrossRefPubMedGoogle Scholar